Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.640
+0.020 (1.23%)
At close: Nov 20, 2024, 4:00 PM
1.600
-0.040 (-2.44%)
Pre-market: Nov 21, 2024, 7:00 AM EST
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $23.55 million as of November 21, 2024. Its market cap has increased by 185.12% in one year.
Market Cap
23.55M
Enterprise Value
11.18M
1-Year Change
185.12%
Ranking
Category
Stock Price
$1.64
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $23.55M, a decrease of -96.27%. That is a compound annual growth rate of -59.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 23.26M | 285.85% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | 631.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cadrenal Therapeutics | 24.43M |
| Equillium | 24.12M |
| Inspira Technologies Oxy B.H.N. | 23.87M |
| Tonix Pharmaceuticals Holding | 23.75M |
| Neuronetics | 23.70M |
| BioXcel Therapeutics | 23.63M |
| AEON Biopharma | 23.59M |
| PolyPid | 23.56M |